共 50 条
- [22] Exploring the safety profile of tremelimumab: an analysis of the FDA adverse event reporting system International Journal of Clinical Pharmacy, 2024, 46 : 480 - 487
- [24] The real-world safety profile of empagliflozin: a disproportionality analysis based on the FDA Adverse Event Reporting System (FAERS) database BMC PHARMACOLOGY & TOXICOLOGY, 2025, 26 (01):